Anhui Lianchuang Biological Medicine Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Anhui LianChuang Biological Medicine Co.,Ltd.

16 YRS

Anhui, China

CNY 20.5 Million

58608 m²

100-500 people

Main Products: Canagliflozin Hemihydrate / 2-(4-Fluorophenyl)-5-[(5-Iodo-2-Methylphenyl)Methyl]Thiophene / Dapagliflozin Propanediol / Dapagliflozin / [(2R,3R,4R,5S,6S)-3,4,5-Triacetyloxy-6-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]Oxan-2-Yl]Methyl Acetate / (2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Hydroxymethyl)-2-Methoxytetrahydro-2H-Pyran-3,4,5-Triol / 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)Benzene / 5-Bromo-2-Chlorobenzoic Acid / Empagliflozin / Acetoxy Empagliflozin / Methyl 1-C-[4-Chloro-3-[[4-[[(3S)-Tetrahydro-3-Furanyl]oxy]Phenyl]Methyl]Phenyl]-Alpha-D-Glucopyranoside / (S)-4-iodo-1-Chloro-2-(4-Tetrahydrofuran-3-Yloxy-Benzyl)-Benzene / (3S)-3-[4-[(5-Bromo-2-Chlorophenyl)Methyl]Phenoxy]Tetrahydro-Furan / 2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone / (S)-(+)-3-Hydroxytetrahydrofuran / Sotagliflozin / 2-(5-Bromo-2-Fluorobenzyl)-1-Benzothiophene / Ipragliflozin / (2S,3R,4S,5S)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6,6-bis(Hydroxymethyl)-2-Methoxytetrahydro-2H-Pyran-3,4,5-Triol / Bexagliflozin / (3S,3'R,4'S,5'S,6'R)-5-[(4-Ethylphenyl)Methyl]-6'-(Hydroxymethyl)Spiro[1H-2-Benzofuran-3,2'-Oxane]-3',4',5'-Triol,Hydrate / 3-Ethoxy-4-Ethoxycarbonylphenylacetic acid / 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-Morpholinyl)Phenyl]-5-Oxazolidinyl]Methyl]-1H-Isoindole-1,3(2H)-Dione / (S)-4-(4-(5-(Aminomethyl)-2-Oxooxazolidin-3-Yl)Phenyl)Morpholin-3-One Hydrochloride / (R)-2-(2-Hydroxy-3-((4-(3-Oxomorpholino)Phenyl)Amino)Propyl)Isoindoline-1,3-Dione / 4-(4-Aminophenyl)Morpholin-3-One / 5-Chlorothiophene-2-Carboxylic Acid / Riociguat / 1-(2-Fluoro-Benzyl)-1H-Pyrazolo[3,4-B]Pyridine-3-Carboxamidine Hydrochloride / 4-Chloro-7-Tosyl-7H-Pyrrolo[2,3-D]Pyrimidine / 4-Chloropyrrolo[2,3-D]Pyrimidine / Pyrrolo[2,3-D]Pyrimidin-4-Ol / Baricitinib / 2-(1-(Ethylsulfonyl)Azetidin-3-Ylidene)Acetonitrile / Abrocitinib / Benzyl 3-Oxocyclobutylcarbamate / Cyclopropanecarboxylic acid (5-Bromo-[1,2,4]Triazolo[1,5-a]Pyridin-2-yl)-Amide / Ruxolitinib / 1-(1-Ethoxyethyl)-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)-1H-Pyrazole / 3-Cyclopentylacrylonitrile / Upadacitinib / Crizotinib / (S)-1-(2,6-Dichloro-3-Fluorophenyl)Ethanol / (R)-5-Bromo-3-(1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)Pyridin-2-Amine / Tert-Butyl 4-[4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazol-1-Yl]Piperidine-1-Carboxylate / (S)-3-Hydroxypyrrolidine / Tedizolid Phosphate / Vonoprazan Fumarate / Tegoprazan / DWP14012 Hydrochloride / Rimegepant Sulfate / Atogepant (MK-8031) / Zavegepant / Ubrogepant / (R)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride / N-T-Butylglycine Hcl / 5-Bromo-2-(2-Methyl-2H-Tetrazol-5-Yl)-Pyridine / 2-(2-Methyl-2H-Tetrazol-5-yl)-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)Pyridine / (R)-3-(4-Bromo-3-Fluorophenyl)-5-(Hydroxymethyl)Oxazolidin-2-One / Torezolid / 2-Cyanoethyl 3-Oxobutanoate / 4-Cyano-2-Methoxybenzaldehyde / Bempedoic acid / (R)-3-Hydroxypyrrolidine / Revaprazan Hydrochloride / (2-Chloro-5-Iodophenyl)[4-[[(3S)-Tetrahydro-3-Furanyl]oxy]Phenyl]Methanone / Vericiguat / 4-Chloro-7H-Pyrrolo[2,3-d]Pyrimidine-7-Carboxylic acid tert-Butyl Ester / Filgotinib Maleate / Elagolix Sodium / 2-(Azetidin-3-Ylidene)Acetonitrile (Hydrochloride) / Tetrabenzyl Pyrophosphate / Asciminib Hydrochloride

Anhui, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

ABOUT US

Anhui Lianchuang Biomedical Co., Ltd. (hereinafter referred to as "the Company") was established in 2009, and its headquarters is located at the west side of Fanhua Avenue in Hefei Economic and Technological Development Zone. It is a high-tech enterprise with a mission of serving health and pursuing technological contributions, and it is an innovative technology company that provides products and technical services to consumers and global pharmaceutical manufacturers. The company's main business includes pharmaceutical raw materials and characteristic intermediates, as well as CRO/CMO/CDMO services for pharmaceutical products. After years of development, the company has assembled a group of specialized research experts and business leaders, excelling in fields such as organic and biological synthesis of pharmaceutical products. Currently, has provided products and technical support to hundreds of global enterprises. This has led to the formation of a product series centered around pharmaceutical raw materials, complemented by characteristic intermediates. The company consistently advocates for innovation and a sharing-driven approach——implementing an actively flexible business model and differentiated product selection in the pursuit of innovative development. In its operational strategy, the company adheres to the principle of maximizing corporate value, aiming to become a platform for mutual consultation, sharing, collaboration, and mutual success for both customers and employees.

Basic Information